Delivery Order SPE2DB22D1017-SPE2DB24FE9KX
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $14,712.39 firm-fixed-price delivery order is for the supply of XARELTO 20 MG TABLET 90S, a pharmaceutical product. The contract has an ultimate completion date of May 16, 2023. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., to deliver a pharmaceutical product called XARELTO 20 MG TABLET 90S. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $20,068.96 and an ultimate completion date of March 27, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The contract, valued at $14,970.96, is a delivery order for the supply of XARELTO 20 MG TABLET 90S, a pharmaceutical product. The contract has an ultimate completion date of January 30, 2024 and is a firm fixed-price agreement. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract, valued at $14,722.62, is for the delivery of XARELTO 20 MG TABLET 90S, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an Ultimate Completion Date of March 11, 2024. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
- This federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of pharmaceutical products, specifically XARELTO 20 MG TABLET 90S. The contract, valued at $9,155.07, is a Firm Fixed Price Delivery Order that will run through September 28, 2023. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds a significant Indefinite Delivery Contract...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $20,965.80 firm fixed-price delivery order is for the supply of XARELTO 20 MG TABLET 90S, a cardiovascular medication, to support military healthcare programs. The contract has an ultimate completion date of February 14, 2022. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $20,451.12 Firm Fixed Price Delivery Order is for the supply of XARELTO 20 MG TABLET 90S, a pharmaceutical product. The award has an ultimate completion date of December 4, 2023. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 and...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $43,674.56 for the supply of XARELTO 20 MG TABLET 90S. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency of the U.S. government, and has an ultimate completion date of February 22, 2024. The contract is a firm fixed-price delivery order with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant...
- This federal contract award, valued at $1,500.74, was issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the delivery of XARELTO 20 MG TABLET 90S. The contract is a firm fixed-price delivery order with a completion date of July 28, 2022. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which also holds a separate $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
- This federal contract award, with ID SPE2DX15D1053|SPE2DX24F6GAK, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $14,075.92 firm fixed-price delivery order is for the supply of XARELTO 20 MG TABLET 90S, a pharmaceutical product. The contract has an ultimate completion date of February 1, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a...
- SPE2DB22D1017Indefinite Delivery Contract
- SPE2DB22D1017-SPE2DB24FE9KXDelivery Order
This federal contract award was granted by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The award, valued at $10,403.96, is a delivery order contract for the supply of XARELTO 20 MG TABLET 90S, a pharmaceutical product. The contract has an ultimate completion date of December 8, 2023 and is a firm fixed-price contract. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products to federal government agencies, particularly within military and veterans' healthcare systems. The company holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026, which serves as the primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This contract award is not designated with a set-aside requirement, indicating open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.4k | 12/7/23 |